 | | ORTHOLOGY: K05400 | |
Entry |
|
Symbol |
LY96, MD-2
|
Name |
|
Pathway |
map04620 | Toll-like receptor signaling pathway |
|
Brite |
KEGG Orthology (KO) [BR:ko00001]
09130 Environmental Information Processing
09132 Signal transduction
04064 NF-kappa B signaling pathway
K05400 LY96, MD-2; lymphocyte antigen 96
09150 Organismal Systems
09151 Immune system
04620 Toll-like receptor signaling pathway
K05400 LY96, MD-2; lymphocyte antigen 96
09160 Human Diseases
09171 Infectious disease: bacterial
05132 Salmonella infection
K05400 LY96, MD-2; lymphocyte antigen 96
05133 Pertussis
K05400 LY96, MD-2; lymphocyte antigen 96
09174 Infectious disease: parasitic
05145 Toxoplasmosis
K05400 LY96, MD-2; lymphocyte antigen 96
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
K05400 LY96, MD-2; lymphocyte antigen 96
09167 Endocrine and metabolic disease
04936 Alcoholic liver disease
K05400 LY96, MD-2; lymphocyte antigen 96
|
Genes |
» show all
|
Reference |
|
Authors |
Shimazu R, Akashi S, Ogata H, Nagai Y, Fukudome K, Miyake K, Kimoto M |
Title |
MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. |
Journal |
|
Sequence |
|
Reference |
|
Authors |
Visintin A, Iliev DB, Monks BG, Halmen KA, Golenbock DT |
Title |
MD-2. |
Journal |
|
LinkDB |
|
|
|